Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 183

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Common Mechanistic Pathways in Cancer and Heart Failure. A Scientific Roadmap on Behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

Open access
de Boer, Rudolf A., Hulot, Jean-Sébastien, Tocchetti, Carlo Gabriele, Aboumsallem, Joseph Pierre, Ameri, Pietro, Anker, Stefan D., Bauersachs, Johann, Bertero, Edoardo, Coats, Andrew J.S., Čelutkienė, Jelena, Chioncel, Ovidiu, Dodion, Pierre, Eschenhagen, Thomas, Farmakis, Dimitrios, Bayes-Genis, Antoni, Jäger, Dirk, Jankowska, Ewa A., Kitsis, Richard N., Konety, Suma H., Larkin, James, Lehmann, Lorenz, Lenihan, Daniel J., Maack, Christoph, Moslehi, Javid J., Müller, Oliver J., Nowak-Sliwinska, Patrycja, Piepoli, Massimo Francesco, Ponikowski, Piotr, Pudil, Radek, Rainer, Peter P., Ruschitzka, Frank, Sawyer, Douglas, Seferovic, Petar M., Suter, Thomas, Thum, Thomas, van der Meer, Peter, Van Laake, Linda W., von Haehling, Stephan, Heymans, Stephane, Lyon, Alexander R., Backs, Johannes·2020·European Journal of Heart Failure

Abstract

The co-occurrence of cancer and heart failure (HF) represents a significant clinical drawback as each disease interferes with the treatment of the other. In addition to shared risk factors, a growing body of experimental and clinical evidence reveals numerous commonalities in the biology underlying both pathologies. Inflammation emerges as a common hallmark for both diseases as it contributes to the initiation and progression of both HF and cancer. Under stress, malignant and cardiac cells change their metabolic preferences to survive, which makes these metabolic derangements a great basis to develop intersection strategies and therapies to combat both diseases. Furthermore, genetic predisposition and clonal haematopoiesis are common drivers for both conditions and they hold great clinical relevance in the context of personalized medicine. Additionally, altered angiogenesis is a common hallmark for failing hearts and tumours and represents a promising substrate to target in both diseases. Cardiac cells and malignant cells interact with their surrounding environment called stroma. This interaction mediates the progression of the two pathologies and understanding the structure and function of each stromal component may pave the way for innovative therapeutic strategies and improved outcomes in patients. The interdisciplinary collaboration between cardiologists and oncologists is essential to establish unified guidelines. To this aim, pre-clinical models that mimic the human situation, where both pathologies coexist, are needed to understand all the aspects of the bidirectional relationship between cancer and HF. Finally, adequately powered clinical studies, including patients from all ages, and men and women, with proper adjudication of both cancer and cardiovascular endpoints, are essential to accurately study these two pathologies at the same time.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ejhf.2029

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 183

Metadata

Authors
de Boer, R. A., Hulot, J.-S., Tocchetti, C. G., Aboumsallem, J. P., Ameri, P., Anker, S. D., Bauersachs, J., Bertero, E., Coats, A. J. S., Čelutkienė, J., Chioncel, O., Dodion, P., Eschenhagen, T., Farmakis, D., Bayes-Genis, A., Jäger, D., Jankowska, E. A., Kitsis, R. N., Konety, S. H., Larkin, J., Lehmann, L., Lenihan, D. J., Maack, C., Moslehi, J. J., Müller, O. J., Nowak-Sliwinska, P., Piepoli, M. F., Ponikowski, P., Pudil, R., Rainer, P. P., Ruschitzka, F., Sawyer, D., Seferovic, P. M., Suter, T., Thum, T., van der Meer, P., Van Laake, L. W., von Haehling, S., Heymans, S., Lyon, A. R., & Backs, J.
Venue
European Journal of Heart Failure
Published
2020-11-12
Volume
22
Issue
12
Pages
2272-2289
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W3093860253
Cited by
183
References
17
FWCI
12.01
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Common Mechanistic Pathways in Cancer and Heart Failure. A Scientific Roadmap on Behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). https://app.cochat.ai/papers/10.1002/ejhf.2029
The paper
de Boer, R. A., Hulot, J.-S., Tocchetti, C. G., Aboumsallem, J. P., Ameri, P., Anker, S. D., Bauersachs, J., Bertero, E., Coats, A. J. S., Čelutkienė, J., Chioncel, O., Dodion, P., Eschenhagen, T., Farmakis, D., Bayes-Genis, A., Jäger, D., Jankowska, E. A., Kitsis, R. N., Konety, S. H., . . . Backs, J. (2020). Common Mechanistic Pathways in Cancer and Heart Failure. A Scientific Roadmap on Behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Journal of Heart Failure. https://doi.org/10.1002/ejhf.2029

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.